Article

Antiviral drug synergy and mutational signatures in different epithelial cell models of RSV and hPIV infection

2026-01-13

Abstract excerpt

Despite the huge global health burden presented by respiratory viruses, effective broad-spectrum antiviral therapeutic options remain limited. Here we evaluated the antiviral activity of four RNA-dependent RNA polymerase (RdRp) inhibitors, remdesivir, ribavirin, favipiravir, and molnupiravir, against respiratory syncytial virus (RSV) and human parainfluenza (hPIV) using monotherapy or dual-drug combinations with e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b8c7eff5-8d1f-5ac8-830e-14254bbfa2b4
DOI: 10.64898/2026.01.13.699296

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Antiviral drug synergy and mutational signatures in different epithelial cell models of RSV and hPIV infectionDOI 10.64898/2026.01.13.699296Read

Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA VirusesSemantic proximity Read

Dynamics of interactions between three major respiratory pathogens in reconstituted human epitheliumSemantic proximity Read

Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium <i>in vitro</i>Semantic proximity Read

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitorSemantic proximity Read

Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery.Semantic proximity Read

EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate modelSemantic proximity Read

Virological and Clinical Outcomes in Adults Treated with Ribavirin Aerosol for COVID-19 PneumoniaSemantic proximity Read

Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitroSemantic proximity Read

Structure-guided design of small-molecule therapeutics against RSV diseaseSemantic proximity Read

Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in miceSemantic proximity Read

Multiple RSV strains infecting HEp-2 and A549 cells reveal cell line-dependent differences in resistance to RSV infectionSemantic proximity Read

Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus AgentsSemantic proximity Read